End Payors Urge 4th Circ. To Revive Celebrex Antitrust Suit
A potential class of health benefit plans told the Fourth Circuit on Tuesday that they're allowed to sue Pfizer Inc. over the tactics it allegedly used to get a patent for...To view the full article, register now.
Already a subscriber? Click here to view full article